Munson Health
 
Gaucher Disease

Back to Document

by Badash M
 

RESOURCES

Gauchers Association
http://www.gaucher.org.uk

National Gaucher Foundation
http://www.gaucherdisease.org

 

CANADIAN RESOURCES

Health Canada
http://www.hc-sc.gc.ca

The National Gaucher Foundation of Canada
http://www.gauchercanada.ca

 

References


About Gaucher. Gauchers Association website. Available at: http://www.gaucher.org.uk/about%5Fgaucher . Accessed August 13, 2013.


Gaucher disease. EBSCO DynaMed website. Available at: https://dynamed.ebscohost.com/about/about-us . Updated March 4, 2013. Accessed August 13, 2013.


Gaucher disease. National Gaucher Foundation website. Available at: http://www.gaucherdisease.org/what%5Fis.php . Accessed August 13, 2013.


Recommendations on the diagnosis, treatment, and monitoring of Gaucher disease. Martins AM, Valadares ER, Porta G, et al. J Pediatrics. 2009;155(4 Suppl):S10-S18.


Shire announces FDA approval of VPRIV (velaglucerase alfa for injection) for the treatment of type 1 Gaucher disease. PR Newswire website. Available at: http://www.prnewswire.com/news-releases/shire-announces-fda-approval-of-vprivtm-velaglucerase-alfa-for-injection-for-the-treatment-of-type-1-gaucher-disease-85554402.html Published February 26, 2010. Accessed August 13, 2013.


3/5/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : FDA approves therapy to treat Gaucher disease. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm202288.htm . Published February 26, 2010. Accessed March 5, 2010.

 

Revision Information